Literature DB >> 35502369

Mitigating the effects of choroidal hyper- and hypo-transmission defects on choroidal vascularity index assessments using optical coherence tomography.

Hao Zhou1, Jie Lu1, Kelly Chen1, Yingying Shi2, Giovanni Gregori2, Philip J Rosenfeld2, Ruikang K Wang1,3.   

Abstract

Background: Changes in choroidal vascularity index (CVI) are associated with multiple choroid-related ocular diseases. CVI is calculated as the area/volume ratio of vessels in the choroid, which could be affected by alterations in regional signal intensities due to hypo-transmission defects (hypoTDs) caused by drusen and retinal pigment epithelium (RPE) detachments, and hyper-transmission defects (hyperTDs) caused by the absence of RPE. To develop a simulation model to verify the CVI assessments in eyes with hyper/hypoTDs and demonstrate that accurate CVIs can be achieved after attenuation correction on swept-source optical coherence tomography (SS-OCT).
Methods: A simulation model was developed on 6×6 mm macular scans from normal subjects. Signal intensity in a cylindrical region below RPE was altered to mimic hyper/hypoTDs. CVIs were compared inside and outside the simulated regions before and after attenuation correction. CVI assessments of OCT scans from patients with hyperTDs due to geographic atrophy (GA) and from patients with hypoTDs due to drusen that subsequently resolved with the disappearance of the hypoTDs were compared with and without attenuation correction.
Results: Ten normal eyes were recruited to generate the hyper/hypoTD simulation model. In eyes with hypoTDs, CVIs were overestimated, and in eyes with hyperTDs, the CVIs were underestimated (P<0.001). After attenuation correction, the uneven distribution of signal intensity was eliminated and the resulting CVI showed no significant difference compared with the 'ground truth', which is measured from the original scans. Attenuation correction successfully eliminated the influence of hyperTDs caused by GA on CVI measurements (n=38). Quantitatively, no significant difference was found in the CVIs of eyes before and after drusen collapse with attenuation correction (n=8). Conclusions: The simulation model could reveal the impact of hypo/hyperTDs on CVI quantification in eyes with choroid-involved ocular diseases. The importance of attenuation correction to ensure accuracy in choroidal vessel segmentation was demonstrated by analyzing eyes with GA or drusen. 2022 Quantitative Imaging in Medicine and Surgery. All rights reserved.

Entities:  

Keywords:  Choroidal vessel quantification; choroidal hyper/hypo-transmission defect; choroidal vascularity index (CVI); drusen; geographic atrophy (GA)

Year:  2022        PMID: 35502369      PMCID: PMC9014140          DOI: 10.21037/qims-21-1093

Source DB:  PubMed          Journal:  Quant Imaging Med Surg        ISSN: 2223-4306


  33 in total

1.  Attenuation correction assisted automatic segmentation for assessing choroidal thickness and vasculature with swept-source OCT.

Authors:  Hao Zhou; Zhongdi Chu; Qinqin Zhang; Yining Dai; Giovanni Gregori; Philip J Rosenfeld; Ruikang K Wang
Journal:  Biomed Opt Express       Date:  2018-11-08       Impact factor: 3.732

2.  CHOROIDAL VASCULARITY INDEX IN CENTRAL SEROUS CHORIORETINOPATHY.

Authors:  Rupesh Agrawal; Jay Chhablani; Kara-Anne Tan; Shilpi Shah; Chintan Sarvaiya; Alay Banker
Journal:  Retina       Date:  2016-09       Impact factor: 4.256

3.  Influence of scanning area on choroidal vascularity index measurement using optical coherence tomography.

Authors:  Rupesh Agrawal; Xin Wei; Abhilash Goud; Kiran Kumar Vupparaboina; Soumya Jana; Jay Chhablani
Journal:  Acta Ophthalmol       Date:  2017-05-04       Impact factor: 3.761

4.  Comparison of Choroidal Vascularity Markers on Optical Coherence Tomography Using Two-Image Binarization Techniques.

Authors:  Xin Wei; Shozo Sonoda; Chitaranjan Mishra; Neha Khandelwal; Ramasamy Kim; Taiji Sakamoto; Rupesh Agrawal
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-03-01       Impact factor: 4.799

5.  Validation of a Compensation Strategy Used to Detect Choriocapillaris Flow Deficits Under Drusen With Swept Source OCT Angiography.

Authors:  Yingying Shi; Zhongdi Chu; Liang Wang; Qinqin Zhang; William Feuer; Luis de Sisternes; Mary K Durbin; Giovanni Gregori; Ruikang K Wang; Philip J Rosenfeld
Journal:  Am J Ophthalmol       Date:  2020-07-02       Impact factor: 5.258

6.  Luminal and stromal areas of choroid determined by binarization method of optical coherence tomographic images.

Authors:  Shozo Sonoda; Taiji Sakamoto; Takehiro Yamashita; Eisuke Uchino; Hiroki Kawano; Naoya Yoshihara; Hiroto Terasaki; Makoto Shirasawa; Masatoshi Tomita; Tatsuro Ishibashi
Journal:  Am J Ophthalmol       Date:  2015-03-17       Impact factor: 5.258

Review 7.  The multifunctional choroid.

Authors:  Debora L Nickla; Josh Wallman
Journal:  Prog Retin Eye Res       Date:  2009-12-29       Impact factor: 21.198

8.  Choroidal Remodeling in Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy: A 12-month Prospective Study.

Authors:  Daniel Shu Wei Ting; Yasuo Yanagi; Rupesh Agrawal; Hwei Yee Teo; Sophia Seen; Ian Yew San Yeo; Ranjana Mathur; Choi Mun Chan; Shu Yen Lee; Edmund Yick Mun Wong; Doric Wong; Tien Yin Wong; Gemmy Chui Ming Cheung
Journal:  Sci Rep       Date:  2017-08-11       Impact factor: 4.379

Review 9.  Pachychoroid disease.

Authors:  Chui Ming Gemmy Cheung; Won Ki Lee; Hideki Koizumi; Kunal Dansingani; Timothy Y Y Lai; K Bailey Freund
Journal:  Eye (Lond)       Date:  2018-07-11       Impact factor: 3.775

Review 10.  Pachychoroid diseases of the macula.

Authors:  Roberto Gallego-Pinazo; Rosa Dolz-Marco; Francisco Gómez-Ulla; Sarah Mrejen; K Bailey Freund
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2014
View more
  1 in total

1.  Depth-resolved visualization and automated quantification of hyperreflective foci on OCT scans using optical attenuation coefficients.

Authors:  Hao Zhou; Jeremy Liu; Rita Laiginhas; Qinqin Zhang; Yuxuan Cheng; Yi Zhang; Yingying Shi; Mengxi Shen; Giovanni Gregori; Philip J Rosenfeld; Ruikang K Wang
Journal:  Biomed Opt Express       Date:  2022-07-07       Impact factor: 3.562

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.